icon-folder.gif   Conference Reports for NATAP  
 
  EASL 44th Annual Meeting
April 22-26, 2009
Copenhagen, Denmark
Back grey_arrow_rt.gif
 
 
 
PegIntron Maintenance Therapy in Cirrhotic (METAVIR F4) HCV Patients Who Failed to Respond to Interferon/Ribavirin (IR) Therapy: Final Results of the EPIC3 Cirrhosis Maintenance Trial
 
 
  Reported by Jules Levin
 
J Bruix, T Poynard, M Colombo, E Schiff, J Reichen, K Burak, EJL Heathcote, T Berg, J-L Poo, C Brandao Mello, R Guenther, C Niederau, R Terg, N Boparai, J Harvey, LH Griffel, M Burroughs, CA Brass, JK Albrecht for the EPIC3 Study Group
 
44th Annual Meeting of the European Association for the Study of the Liver
Friday, April 24, 2009
Copenhagen, Denmark

Aims-1.gif

Maee-2.gif

Design-3.gif

Method-4.gif

Roll-5.gif

Time-6.gif

Prog-7.gif

rnad-8.gif

time-9.gif

by-10.gif

summe-11.gif

group-12.gif